Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sjögren Syndrome

Atsuro Uchida, Miki Uchino, Eiki Goto, Eri Hosaka, Yuko Kasuya, Kazumi Fukagawa, Murat Dogru, Yoko Ogawa, Kazuo Tsubota

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Purpose: To compare noninvasive tear meniscus height (NI-TMH) using a tear interference device in normal subjects and dry eye patients with Sjögren syndrome (SS), and to investigate the applicability of this new method before and after the punctal occlusion procedure. Design: Prospective case control study. Methods: Tear meniscus was visualized noninvasively using a tear interference device (Tearscope plus, Keeler, Windsor, United Kingdom). Tear interference image was captured with digital video camera (SP-321, JFC Sales Plan Co, Tokyo, Japan) attached to the slit-lamp. Lower lid margin NI-TMH was measured using image analysis software. NI-TMH of 28 eyes from 17 normal subjects and 46 eyes from 27 aqueous tear deficiency (ATD) dry eye patients with SS were compared. The change of NI-TMH three weeks after the successful punctal occlusion was examined in 11 eyes of eight dry eye subjects. Results: Tear meniscus was well visualized with the tear interference device in all cases. Lower lid margin NI-TMH was 0.22 ± 0.065 mm in normal subjects, and 0.13 ± 0.042 mm in SS subjects, respectively (P < .0001). After the punctal occlusion, lower lid margin NI-TMH increased significantly from 0.12 ± 0.026 mm to 0.42 ± 0.21 mm (P = .001). Conclusions: NI-TMH was substantially lower in SS subjects and also significantly improved after punctal occlusion. This method is expected to be helpful in the diagnosis and in the evaluation of the efficacy of punctal occlusion in ATD dry eyes such as SS.

Original languageEnglish
JournalAmerican Journal of Ophthalmology
Volume144
Issue number2
DOIs
Publication statusPublished - 2007 Aug

Fingerprint

Tears
Equipment and Supplies
Meniscus
Tokyo
Case-Control Studies
Japan
Software

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sjögren Syndrome. / Uchida, Atsuro; Uchino, Miki; Goto, Eiki; Hosaka, Eri; Kasuya, Yuko; Fukagawa, Kazumi; Dogru, Murat; Ogawa, Yoko; Tsubota, Kazuo.

In: American Journal of Ophthalmology, Vol. 144, No. 2, 08.2007.

Research output: Contribution to journalArticle

Uchida, Atsuro ; Uchino, Miki ; Goto, Eiki ; Hosaka, Eri ; Kasuya, Yuko ; Fukagawa, Kazumi ; Dogru, Murat ; Ogawa, Yoko ; Tsubota, Kazuo. / Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sjögren Syndrome. In: American Journal of Ophthalmology. 2007 ; Vol. 144, No. 2.
@article{e4e46abaf62346678e53abc815b82906,
title = "Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sj{\"o}gren Syndrome",
abstract = "Purpose: To compare noninvasive tear meniscus height (NI-TMH) using a tear interference device in normal subjects and dry eye patients with Sj{\"o}gren syndrome (SS), and to investigate the applicability of this new method before and after the punctal occlusion procedure. Design: Prospective case control study. Methods: Tear meniscus was visualized noninvasively using a tear interference device (Tearscope plus, Keeler, Windsor, United Kingdom). Tear interference image was captured with digital video camera (SP-321, JFC Sales Plan Co, Tokyo, Japan) attached to the slit-lamp. Lower lid margin NI-TMH was measured using image analysis software. NI-TMH of 28 eyes from 17 normal subjects and 46 eyes from 27 aqueous tear deficiency (ATD) dry eye patients with SS were compared. The change of NI-TMH three weeks after the successful punctal occlusion was examined in 11 eyes of eight dry eye subjects. Results: Tear meniscus was well visualized with the tear interference device in all cases. Lower lid margin NI-TMH was 0.22 ± 0.065 mm in normal subjects, and 0.13 ± 0.042 mm in SS subjects, respectively (P < .0001). After the punctal occlusion, lower lid margin NI-TMH increased significantly from 0.12 ± 0.026 mm to 0.42 ± 0.21 mm (P = .001). Conclusions: NI-TMH was substantially lower in SS subjects and also significantly improved after punctal occlusion. This method is expected to be helpful in the diagnosis and in the evaluation of the efficacy of punctal occlusion in ATD dry eyes such as SS.",
author = "Atsuro Uchida and Miki Uchino and Eiki Goto and Eri Hosaka and Yuko Kasuya and Kazumi Fukagawa and Murat Dogru and Yoko Ogawa and Kazuo Tsubota",
year = "2007",
month = "8",
doi = "10.1016/j.ajo.2007.04.006",
language = "English",
volume = "144",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Noninvasive Interference Tear Meniscometry in Dry Eye Patients With Sjögren Syndrome

AU - Uchida, Atsuro

AU - Uchino, Miki

AU - Goto, Eiki

AU - Hosaka, Eri

AU - Kasuya, Yuko

AU - Fukagawa, Kazumi

AU - Dogru, Murat

AU - Ogawa, Yoko

AU - Tsubota, Kazuo

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: To compare noninvasive tear meniscus height (NI-TMH) using a tear interference device in normal subjects and dry eye patients with Sjögren syndrome (SS), and to investigate the applicability of this new method before and after the punctal occlusion procedure. Design: Prospective case control study. Methods: Tear meniscus was visualized noninvasively using a tear interference device (Tearscope plus, Keeler, Windsor, United Kingdom). Tear interference image was captured with digital video camera (SP-321, JFC Sales Plan Co, Tokyo, Japan) attached to the slit-lamp. Lower lid margin NI-TMH was measured using image analysis software. NI-TMH of 28 eyes from 17 normal subjects and 46 eyes from 27 aqueous tear deficiency (ATD) dry eye patients with SS were compared. The change of NI-TMH three weeks after the successful punctal occlusion was examined in 11 eyes of eight dry eye subjects. Results: Tear meniscus was well visualized with the tear interference device in all cases. Lower lid margin NI-TMH was 0.22 ± 0.065 mm in normal subjects, and 0.13 ± 0.042 mm in SS subjects, respectively (P < .0001). After the punctal occlusion, lower lid margin NI-TMH increased significantly from 0.12 ± 0.026 mm to 0.42 ± 0.21 mm (P = .001). Conclusions: NI-TMH was substantially lower in SS subjects and also significantly improved after punctal occlusion. This method is expected to be helpful in the diagnosis and in the evaluation of the efficacy of punctal occlusion in ATD dry eyes such as SS.

AB - Purpose: To compare noninvasive tear meniscus height (NI-TMH) using a tear interference device in normal subjects and dry eye patients with Sjögren syndrome (SS), and to investigate the applicability of this new method before and after the punctal occlusion procedure. Design: Prospective case control study. Methods: Tear meniscus was visualized noninvasively using a tear interference device (Tearscope plus, Keeler, Windsor, United Kingdom). Tear interference image was captured with digital video camera (SP-321, JFC Sales Plan Co, Tokyo, Japan) attached to the slit-lamp. Lower lid margin NI-TMH was measured using image analysis software. NI-TMH of 28 eyes from 17 normal subjects and 46 eyes from 27 aqueous tear deficiency (ATD) dry eye patients with SS were compared. The change of NI-TMH three weeks after the successful punctal occlusion was examined in 11 eyes of eight dry eye subjects. Results: Tear meniscus was well visualized with the tear interference device in all cases. Lower lid margin NI-TMH was 0.22 ± 0.065 mm in normal subjects, and 0.13 ± 0.042 mm in SS subjects, respectively (P < .0001). After the punctal occlusion, lower lid margin NI-TMH increased significantly from 0.12 ± 0.026 mm to 0.42 ± 0.21 mm (P = .001). Conclusions: NI-TMH was substantially lower in SS subjects and also significantly improved after punctal occlusion. This method is expected to be helpful in the diagnosis and in the evaluation of the efficacy of punctal occlusion in ATD dry eyes such as SS.

UR - http://www.scopus.com/inward/record.url?scp=34447622127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447622127&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2007.04.006

DO - 10.1016/j.ajo.2007.04.006

M3 - Article

VL - 144

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 2

ER -